Danske Bank’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.81K Hold
300
﹤0.01% 888
2026
Q1
$6.99K Sell
300
-2,700
-90% -$58.2K ﹤0.01% 863
2025
Q4
$60K Hold
3,000
﹤0.01% 927
2025
Q3
$54.8K Hold
3,000
﹤0.01% 993
2025
Q2
$60.3K Buy
3,000
+2,800
+1,400% +$53.8K ﹤0.01% 978
2025
Q1
$3.63K Hold
200
﹤0.01% 1200
2024
Q4
$3.47K Sell
200
-4,300
-96% -$82.6K ﹤0.01% 1234
2024
Q3
$86.9K Sell
4,500
-1,058
-19% -$19.5K ﹤0.01% 1050
2024
Q2
$91.2K Hold
5,558
﹤0.01% 950
2024
Q1
$84.7K Buy
+5,558
New +$87.3K ﹤0.01% 982

Other funds holding INVA

Danske Bank's INVA Position: Q2 2026 in Review

Danske Bank held its Innoviva (INVA) position steady in Q2 2026 at 300 shares worth $6.81K. The position accounts for ﹤0.01% of the portfolio, ranked #888.

Danske Bank first reported a position in INVA in Q1 2024 and has held it in 10 quarters since. The position peaked at $91.2K in Q2 2024. 236 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Danske Bank held 300 shares of Innoviva worth $6.81K as of Q2 2026.
  • Danske Bank left its Innoviva share count unchanged in Q2 2026.
  • Innoviva made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #888 holding.
  • Danske Bank first reported a position in Innoviva in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Innoviva position peaked at $91.2K in Q2 2024.
  • 236 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.